EPICS Therapeutics
Our Expertise
Our Science
Our Pipeline
EP102: METTL3
EP282: FFAR2
EP601: GPR84
Our Clinical Trial
News & Publications
Contact Us
Search
Search
Search
NEWS & EVENTS
Increased regulatory activity of intestinal innate lymphoid cells type 3 (ILC3) prevents experimental autoimmune encephalomyelitis severity
Discover our pipeline
Contact us
Please check out this link :
link.springer.com